Shape Memory Medical Inc.

Shape Memory Medical Inc., doing business as Shape Memory Therapeutics, is a for-profit manufacturer of medical devices headquartered in San Jose, California. The company specializes in developing innovative therapeutic solutions for vascular applications using smart polymer technology. Through its federal award portfolio, Shape Memory Therapeutics provides specialized surgical implants and medical devices to support the missions of federal healthcare agencies and research institutions, with a particular focus on products designed for hemorrhage control and vascular interventions.

Shape Memory Therapeutics has secured federal contract awards exclusively through the Department of Veterans Affairs, demonstrating its capability to supply specialized medical devices to support veteran healthcare initiatives. The company received two purchase orders, both valued at $17,500 each, with no set-aside designations applied. The first purchase order was awarded by Veterans Integrated Service Network 8 on November 28, 2023, for surgical implants with performance conducted in Santa Clara, California and an ultimate completion date of July 31, 2024. The second purchase order was awarded by Veterans Integrated Service Network 10 on December 8, 2025, for embolization plugs to be performed at the contractor's San Jose, California facility with an ultimate completion date of December 29, 2025. Both awards represent focused procurements of surgical implants designed to enhance the quality of healthcare delivery to veterans across their respective service regions.

Shape Memory Therapeutics has participated in federal grant activities primarily as a sub-awardee under grants administered by Syracuse University and Texas A&M Engineering Experiment Station. The company has been involved in multiple sub-grant awards focused on advancing smart polymer foam technology for hemorrhage control applications. A sub-award dated July 22, 2024, from Syracuse University tasked Shape Memory Therapeutics with providing engineering design and project management services, including coordination with grant personnel and graduate students, conducting annual site visits, and ensuring commercialization alignment for smart polymer foam products. An earlier sub-award from March 21, 2024, also from Syracuse University, engaged the company to provide expertise in experimental design and analysis, biocompatibility testing coordination, and regulatory strategy development to support FDA submission pathways for hemorrhage control devices. Additionally, the company participated in sub-awards dated May 17, 2022, and July 9, 2021, related to the development of biopsy tract sealing devices with magnetic resonance and x-ray image contrast capabilities. Through these grant activities, Shape Memory Therapeutics has contributed its specialized expertise in smart polymer materials and regulatory compliance to support the translational research and commercialization efforts of its academic and governmental partners.